- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
210
13 new
Companies with a Value score of at least 3, ordered by Value score
210 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
0O1O | €66.90 | -5.8% | -37.4% | €789.2m | €96.86 | PE16.7x | E8.9% | 1.3% | ||
0O9B | €8.54 | 2.3% | -0.9% | €1.8b | €11.78 | PS1.9x | E45.2% | 2.2% | ||
HVO | UK£0.19 | 8.6% | -26.2% | UK£129.3m | UK£0.35 | PE7.4x | E-18.4% | 1.1% | ||
0ILL | €62.50 | 6.4% | -2.0% | €3.2b | €88.53 | PE19.4x | E15.5% | 1.8% | ||
0NM7 | €308.50 | -1.9% | -8.6% | €2.6b | €397.59 | PE18.3x | E10.6% | 0.4% | ||
0HB0 | US$32.83 | -2.0% | 51.3% | US$1.8b | US$57.72 | PE2.7x | E-29.8% | n/a | ||
0ND5 | DKK 40.07 | 1.0% | 14.3% | DKK 38.6b | DKK 49.71 | PE14.9x | E7.4% | 1.7% | ||
INDV | UK£9.92 | 8.7% | -26.5% | UK£1.2b | UK£13.12 | PS1.3x | E42.6% | 0% | ||
INDVL | UK£9.91 | 8.2% | -26.9% | UK£1.2b | UK£13.10 | PS1.3x | E42.6% | 0% | ||
0NTI | €65.76 | 0.5% | -30.3% | €2.3b | €108.11 | PE20.3x | E21.8% | 1.9% | ||
1SXPD | €23.72 | -7.6% | n/a | €3.8b | €29.46 | PE25.5x | E14.1% | 0.6% | ||
0QLR | CHF 89.36 | -0.8% | -4.5% | CHF 178.7b | CHF 101.93 | PE16.7x | E7.2% | 3.6% | ||
0A5V | US$11.38 | -4.1% | -3.2% | US$13.5b | US$13.54 | PS0.9x | E51.6% | 4.2% | ||
COPNZ | CHF 65.20 | 2.7% | 5.5% | CHF 1.0b | CHF 98.07 | PE16x | E21.5% | 2.9% | ||
NOVNz | CHF 89.64 | -0.5% | -4.0% | CHF 178.7b | CHF 102.25 | PE16.7x | E7.2% | 3.6% | ||
0J2O | US$55.59 | 2.9% | 62.7% | US$7.0b | US$65.68 | PE17.8x | E17.3% | n/a | ||
0QCO | €0.90 | 0.8% | -20.3% | €603.7m | €1.86 | PS2.2x | E57.2% | n/a | ||
0K16 | US$13.67 | 46.8% | 16.0% | US$665.5m | US$23.75 | PS3.4x | E59.4% | n/a | ||
0TDF | US$36.38 | 1.0% | 3.9% | US$214.6b | US$41.36 | PE20x | E10.5% | 3.6% | ||
0JDM | US$203.95 | 1.4% | -4.5% | US$35.8b | US$257.35 | PE25.5x | E13.7% | 0% | ||
0A4W | US$17.89 | 3.8% | -36.6% | US$2.9b | US$25.40 | PE22.7x | E23.7% | n/a | ||
SDZZ | CHF 41.60 | 8.2% | 42.7% | CHF 18.3b | CHF 44.34 | PS2x | E29.7% | 1.1% | ||
APH | UK£0.61 | 0% | 60.2% | UK£330.3m | UK£0.63 | PS1.8x | E65.7% | 0% | ||
0QAV | €3.19 | 8.2% | -55.1% | €152.6m | €11.07 | PS3.6x | E32.9% | n/a |